Company	Share, %
Rain Therapeutics Inc.	13.56
Reneo Pharmaceuticals, Inc.	9.96
CytomX Therapeutics, Inc.	9.67
Bolt Biotherapeutics, Inc.	9.58
LianBio	8.67
TCR2 Therapeutics Inc.	8.66
Quince Therapeutics, Inc.	7.45
AnaptysBio, Inc.	7.29
Tarsus Pharmaceuticals, Inc.	6.44
Elevation Oncology, Inc.	5.6
Kinnate Biopharma Inc.	5.51
BioAtla, Inc.	5.25
MEI Pharma, Inc.	4.89
Atea Pharmaceuticals, Inc.	4.84
Passage Bio, Inc.	4.32
Altimmune, Inc.	3.88
Black Diamond Therapeutics, Inc.	3.49
Graphite Bio, Inc.	3.48
Ventyx Biosciences, Inc.	3.38
Enzo Biochem, Inc.	3.32
Lava Therapeutics B.V.	3.2
Amarin	3.12
Aligos Therapeutics, Inc.	2.89
Adaptimmune Therapeutics plc	2.84
Design Therapeutics, Inc.	2.62
Aclaris Therapeutics, Inc.	2.47
Athira Pharma, Inc.	2.22
NextCure, Inc.	1.68
Precision BioSciences, Inc.	1.64
Nuvation Bio Inc.	1.61
Aurinia Pharmaceuticals Inc.	1.44
InflaRx N.V.	1.31
AcelRx Pharmaceuticals, Inc.	1.19
Equillium, Inc.	1.13
Century Therapeutics, Inc.	1.08
Genfit S.A.	0.96
Inspirato Incorporated	0.56
TransCode Therapeutics, Inc.	0.33
Molecular Partners AG	0.27